News Sentiment

MBRX sentiment intelligence

Moleculin Biotech Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.10 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

76/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-7.9% over one week, -27.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Biotech stocks lead healthcare's overbought list as earnings picks up (XLV:NYSEARCA)

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 76/100 classification
One-week reaction -7.9% Price reacting lower
Trend fit Trend inactive -27.1% over four weeks
Fair value -97.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 37
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 11
GlobeNewswire 8
Market source 7
Stock Titan 5
Moomoo 4
Investing.com 4
Stocktwits 2
Quiver Quantitative 2

Event Lens

What the news is about

Classified themes
Earnings 28
Market update 25
Analyst action 3
Regulatory and legal 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58
TradingView Direct company coverage

0K2H Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Moleculin Biotech, Inc. (0K2H) stock, listed on the London Stock Exchange. It includes analyst ratings, future price estimates, and key financial metrics such as earnings, revenue, and market capitalization. The stock's perfor

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 00:39
Source
TradingView
TradingView Direct company coverage

Moleculin Biotech, Inc. Actuals & Estimates (LSE:0K2H)

This article provides an overview of Moleculin Biotech, Inc. (LSE:0K2H) stock performance, financial actuals, and analyst estimates. It details recent price changes, historical highs and lows, market capitalization, and upcoming earnings reports. The piece also includes frequentl

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 19:11
Source
TradingView